DuPont (DD) slipped on Thursday after its first quarter missed analysts' estimates.
The conglomerate said it earned $1.44 billion or $1.54 a share; excluding one-time items, per-share earnings were $1.58 a share, up two cents from the year-ago period but a penny below the $1.59 consensus.
Revenue slipped 2.7% to $10.1 billion, also below the $10.45 analysts were expecting.
The company noted that the extraordinarily harsh winter in many parts of the country hurt the results, to the tune of seven cents a share, as farmers delayed buying seeds and other agricultural products. Political uncertainty also disrupted sales in Ukraine, one of the world's largest corn and wheat exporters.
S&P Capital IQ's Christopher Muir was downbeat about the prospect of DuPont's outlook improving in the near term, lowering his rating on the stock to Sell from Hold, and lowered his target price by $1 to $64. "We negatively view the 3.4% year-over-year drop in sales, though the drop was more than offset by strong cost control efforts. Q1 recurring EPS of $1.58, vs. $1.56, missed our $1.76 estimate and the $1.59 Capital IQ consensus. The shares are yielding 2.7%.
By contrast, Citigroup's P.J. Juvekar reiterated a Buy rating and $78 price target, noting that the company executes as well as could be expected in poor weather conditions, and that its full-year guidance and share repurchase plan are positives: "DD reported 1Q14 EPS of $1.58 vs. our $1.56 and consensus of $1.58. The company explicitly called out a 7c/share impact from adverse weather conditions in 1Q, reflecting a combination of higher operating costs and lost sales. 2014 EPS guidance of $4.20-$4.45 was reaffirmed, with an estimated 70% of FY14 EPS expected in 1H. DD repurchased ~$1B of stock in 1Q, more than we anticipated, and is well-positioned to complete the targeted $2B of stock this year. The Perf Chemicals separation is on track for mid-2015, with physical separation of manufacturing sites underway and initial regulatory filings expected in 4Q14."
No comments:
Post a Comment